Part of the National Cancer Moonshot, GDC to centralise, standardise accessible data.
Over 1000 people have their genome sequenced to understand why some people’s brains age better than others
Testing for metabolic changes in the blood could indicate whether a cancer drug is working as designed, a new study reports
Next-generation gene sequencing in newborns in neonatal intensive care units could improve diagnosis of rare diseases according to new research
Testing cancers for ‘addiction’ to a gene that boosts cell growth can pick out patients who may respond to a targeted drug under development
NEJM study is one of the first to show the life-changing benefits of genome-wide sequencing for children with certain kinds of intellectual disability
USC-led study reveals that melanoma patients with deficient or mutant copies of the gene are less protected from harmful ultraviolet rays
Nationwide Foundation Pediatric Innovation Fund bolsters recruitment of international genomics leaders to Nationwide Children’s Hospital
Nationwide Children’s Hospital has recruited Richard Wilson and Elaine Mardis, marking a transformational milestone for its genomics research program.
Lung cancer spread in mice is slowed by tampering with a specific protein pathway, suggesting a potential new therapy target for the disease
Edico Genome awarded new bioinformatic patent covering the the technology and methods of use at the core of their DRAGEN Processor
Using gene editing researchers have successfully excised a segment of HIV-1 DNA from the genomes of living animals.
Sophia Genetics and Multiplicom partner to accelerate adoption of Next-Generation Sequencing (NGS) in routine clinical diagnostics
Sophia Genetics and Multiplicom today announce a partnership to accelerate the adoption of Next-Generation Sequencing (NGS) in routine clinical diagnostics
A molecular pathway activated in the brain during fasting helps halt the spread of intestinal bacteria into the bloodstream
Researchers at the University of Missouri have developed a gene replacement therapy to treat spinal muscular atrophy.
iGenomX’s novel library construction method is set to power suite of DNA sequencing applications.